As the Guardian of the Treaties, the European Commission has today sent a letter of formal notice to the United Kingdom for breaching its EU Treaty obligations by not suggesting a candidate for the post of EU Commissioner. The UK authorities have until Friday 22 November at the latest to provide their views. This short time period is justified by the fact that the next Commission must enter into office as soon as possible.
The meeting highlights are now available.
The European Medicines Agency (EMA) is advising marketing authorisation holders to submit type IA and type IAIN variations for 2019 no later than Friday 29 November 2019. This will enable EMA to acknowledge the validity of the submissions before the Agency’s closure between 23 December 2019 and 6 January 2020 and within the 30-day timeframe set out in Article 14 of Commission Regulation (EC) No 1234/2008.
Update: the Decision has been published in the Official Journal.
The European Council has adopted a decision to extend the period under Article 50.3 (of the Treaty on the European Union), in the context of the UK’s intention to withdraw from the EU.
The extension will last until 31 January 2020 to allow more time for the ratification of the withdrawal agreement. The withdrawal can take place earlier on 1 December 2019 or 1 January 2020, if the withdrawal agreement is ratified by both parties.
Answer given by Ms Thyssen on behalf of the European Commission to a question (Rule 138) by Antony Hook (Renew) on Disruption to medical treatment because of Brexit.